• support@madhedgefundtrader.com
  • Member Login
Mad Hedge Fund Trader
  • Home
  • About
  • Store
  • Luncheons
  • Testimonials
  • Contact Us
  • Click to open the search input field Click to open the search input field Search
  • Menu Menu
april@madhedgefundtrader.com

November 7, 2024

Biotech Letter

Mad Hedge Biotech and Healthcare Letter
November 7, 2024
Fiat Lux

 

Featured Trade:

(COPENHAGEN’S CASH COW)

(NVO), (LLY), (AMGN), (RHHBY), (PFE)

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2024-11-07 12:02:492024-11-07 12:17:32November 7, 2024
april@madhedgefundtrader.com

Copenhagen's Cash Cow

Biotech Letter

The first time I visited Denmark, my taxi driver had an unusual conversation starter.

"You know what's our biggest company?" he asked, navigating Copenhagen's rain-slicked streets. "Not LEGO, not Maersk. It's the diabetes people." He was right.

Novo Nordisk (NVO), which began in the 1920s with a borrowed insulin recipe and a dream of treating diabetes, has morphed into Denmark's crown jewel of pharmaceuticals.

The company that once extracted insulin from cow pancreases (collected by the truckload from local slaughterhouses) is now making the kind of money that would make a Viking raid look like pocket change.

In the third quarter of 2024 alone, Novo Nordisk reported a 21% profit surge to 27.3 billion Danish kroner (that's $2.45 billion for those of us who don't speak currency converter).

The star of this financial show? A drug called Wegovy, whose sales have skyrocketed to 17.3 billion kroner in Q3, leaving analysts' predictions in the dust like a marathoner who's found an extra gear.

But before we pop the champagne (or the sugar-free sparkling water, given the company's focus), let's peek behind the Danish curtain.

The story of Novo Nordisk is like watching a high-wire act at the circus - thrilling, precisely executed, but with plenty of observers holding their breath about what could go wrong.

But, it's now a far cry from the days when company founders Harald and Thorvald Pedersen would personally deliver insulin to local pharmacies by bicycle.

The company has carved out its empire in the rather unglamorous-sounding GLP-1 receptor agonist market.

Don't let the clunky name fool you - this market was worth a hefty $36.79 billion in 2023 and is growing faster than bacteria in a petri dish, with projections showing a 21.65% annual growth rate from 2024 to 2030.

By 2031, we're looking at a potential $150 billion market, with obesity treatments accounting for $90 billion of that pie.

Novo Nordisk's triple threat - Wegovy, Ozempic, and Rybelsus - have been dominating this space like a scientific dream team.

Not bad for a company that once had to import porcine intestines from China to keep up with insulin production in the 1960s.

But success attracts competition like moths to a flame, and the flames are getting crowded.

Enter Eli Lilly (LLY), strutting into the party with Mounjaro, which raked in $1.5 billion in Q2 2024 sales alone - a 71% quarterly growth that probably caused some sleepless nights in Denmark.

Meanwhile, Amgen (AMGN) and Viking Therapeutics (VKTX) are cooking up their own weight-loss concoctions in their respective labs.

Viking's oral GLP-1 drug is particularly interesting - imagine taking a pill instead of giving yourself a shot. For needle-phobic patients, that's like choosing between a day at the spa and a day at the dentist.

Speaking of setbacks, Novo Nordisk recently had to wave the white flag on ocedurenone, their hoped-for kidney disease drug.

After spending $1.3 billion to acquire it from KBP Biosciences (ouch), the phase 3 trial results came back with all the excitement of a flat sofa.

The company had to write off $816.5 million - the kind of number that makes accountants reach for the antacids.

Now they're left with just one CKD program based on semaglutide, the same ingredient that makes Wegovy, Ozempic, and Rybelsus tick. It's a reminder that even in the age of sophisticated molecular modeling and AI-driven drug discovery, pharmaceutical development can still be as unpredictable as Danish weather.

As if that weren't enough to keep executives up at night, Hims & Hers Health (HIMS) is preparing to crash the party with a generic version of liraglutide (the secret sauce in Novo's older drugs Victoza and Saxenda) as soon as 2025.

While these older medications contribute less than 10% to Novo's revenue, it's like watching the first raindrops of what could become a storm.

The ghosts of those early insulin-producing pancreases might be chuckling at how history repeats itself - from fighting for insulin patents in the 1920s to defending weight loss drug territory today.

The company's stock currently trades at a forward P/E ratio of 33.2x, with analysts expecting a 22.4% annual earnings growth through 2025.

That's the kind of valuation that makes value investors break out in hives - 37 times trailing earnings and 12.95 times trailing sales means this stock is priced like a luxury handbag, where any scuff could send the price tumbling.

For those eyeing Novo Nordisk like a dessert cart at a weight-loss clinic, the decision isn't simple.

The company's dominance in the GLP-1 market is impressive, but with competitors like Eli Lilly, Amgen, and Pfizer (PFE) circling like hungry sharks, and Roche's (RHHBY) recent acquisition of Carmot Therapeutics adding another player to the mix, the waters are getting choppy.

The prudent move? Current shareholders might want to hold onto their tickets for this roller coaster ride while keeping a white-knuckled grip on the safety bar.

New investors might want to wait in line until the price becomes more reasonable - like waiting for the post-holiday sale at a luxury boutique.

And for those looking to spread their bets, Eli Lilly, Amgen, and Roche offer alternative ways to play in this space, each with their own mix of risk and potential reward.

Anyway, going back to that taxi driver in Copenhagen? He had one more thing to say: "Those Novo people, they started with dead cows and now they're making drugs from bacteria in giant steel tanks. Who knows what they'll do next?"

Indeed, from slaughterhouse pancreases to billion-dollar weight loss drugs, Novo Nordisk's story reads like a scientific fairy tale. But in the world of biotech investing, even fairy tales need solid earnings reports.

For now, this Danish giant continues to prove that sometimes the best investment stories start with someone asking, "What if we could do this better?" - even if "this" means figuring out how to get insulin from a cow pancreas.

 

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2024-11-07 12:00:312024-11-07 12:17:26Copenhagen's Cash Cow
april@madhedgefundtrader.com

Trade Alert - (TSLA) November 7, 2024 - BUY

Trade Alert

When John identifies a strategic exit point, he will send you an alert with specific trade information as to what security to sell, when to sell it, and at what price. Most often, it will be to TAKE PROFITS, but on rare occasions, it will be to exercise a STOP LOSS at a predetermined price to adhere to strict risk management discipline. Read more

https://www.madhedgefundtrader.com/wp-content/uploads/2016/02/Alert-e1457452190575.jpg 135 150 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2024-11-07 10:58:082024-11-07 11:06:08Trade Alert - (TSLA) November 7, 2024 - BUY
april@madhedgefundtrader.com

November 7, 2024

Diary, Newsletter, Summary

Global Market Comments
November 7, 2024
Fiat Lux

 

Featured Trade:

(REITERATION OF MY $1,000 TARGET FOR TESLA),
(TSLA)

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2024-11-07 09:04:062024-11-07 10:47:14November 7, 2024
april@madhedgefundtrader.com

Tesla Special Report: From Here to Infiniti

Diary, Newsletter

OK, let me take my victory lap.

Since I sent out my trade alert to buy Tesla on August 5, Tesla shares have exploded upward by a breathtaking $110, or 61%, to $290, a new 2024 high.

And the best is yet to come!

Of course, we got an assist from several fronts. The Tesla Model Y became the world’s top-selling car, just edging out the Toyota Corolla. Then, both Ford (F) and General Motors (GM) signed on to use Tesla’s national supercharger network, giving it an effective monopoly.

Now Elon Musk has a Trump administration to look forward to, where Musk donated hundreds of millions of dollars. What Elon will get in exchange is the elimination of regulation from his many companies, which until now have been very heavily regulated. It was a bargain at the price. Full Self Driving in the US, until now only available in unregulated China. No problem!

Elon Musk unveiled his Master Plan 3 and unleashed a cornucopia of new data that only an immense amount of research can produce. This will require all forms of transportation to be electric-powered within 20 years, except for interplanetary rockets.

As anyone who has been through an advanced physics course can tell you, internal combustion engines are woefully inefficient, converting only 25% of their energy into forward motion and 20% if you include materials energy costs. But then, that was the best the 19th century could do, and it worked for 152 years (Nicolaus Otto built the first gasoline-powered internal combustion engine in Germany in 1872).

Electric motors in Teslas operate closer to a 50% efficiency rating, cutting energy demand by half right there.

To move the world to an all-electric economy will cost about $10 trillion, or about 10% of world GDP. Average that out at 0.5% per year, and it will take about 20 years. Adding up car and storage batteries means 24 terawatts worth of batteries will need to be manufactured. There are one trillion watts per terawatt.

By comparison, the sun produces 1 gigawatt of energy per square kilometer per day or 509,600 terawatts. That means an all-electric economy dependent on batteries equivalent to less than 0.1% of the sun’s daily output. In other words, it’s miniscule.

In fact, the world is already decarbonizing far faster than people realize.

There are currently 2 billion cars and trucks in the world, 85 million a year are manufactured, and some 16 million in the US. Global EV production came to 10.6 million vehicles in 2023, an increase of 22%.

Some 60% of new electricity generation installed last year came from alternatives. That’s because, in terms of power output, alternatives are 40% cheaper than oil, coal, or natural gas. That’s being generous as it does not include the health care costs of carbon-based energy, which make several hundred thousand people per year ill in the US alone (asthma, lung cancer, etc.).

This means that a heck of a lot of lithium is going to be needed. Soft, white lithium is number three on the period table (you’re talking to a chemist here), is a great oxidizer, and is anything but rare. What IS rare is the lack of environmental controls and cheap labor.

This is why the bulk of lithium is produced in China and South America, where it literally sits on the surface. This is all easily scalable to meet future demand. In fact, moving to an alternative-based world uses far less mining than the existing conventional one.

The shortage is not in lithium supply but in lithium processing. The world’s largest lithium consumer should know. This is why Musk recently moved into lithium processing last year.

Home heating is another challenge. Existing heat pumps, which I have, do a great job heating in winter and cooling in summer in southern and western states where the weather is mild. These use only one-third of the energy used to heat homes with oil and natural gas.  States facing subzero temperatures are another story. This problem can be solved with a fundamental redesign of the heat pump hardware.

Here was a big surprise for me. EV’s are not going to create an exponential demand for lithium. Otherwise, lithium stocks would be a lot higher. Once you get up to a total installed base of 40 million batteries, recycling becomes the primary sources of lithium as batteries age out. They can then be reprocessed into new batteries. This eventually caps lithium demand. Future cars will use far less silicon carbide, further reducing its demand by 75%, saving $1,000 a car.

Musk is dumping the traditional 12-volt lead acid battery all Teslas have now, which accounts for 87% of all start failures. Instead, he is adding a second small lithium-ion one and redesigning the electrics to take 48 volts. This means lighter-weight cables can handle more power at less cost. Musk hopes to force the entire auto industry to move to a 48-volt standard, which should have been done decades ago.

The world’s 7 million Teslas now drive 123 million miles a day and represent the largest AI neural network on the planet. If a car in Florida makes a left turn, all the cars in the rest of the country learn from that experience.

Tesla now has 80,000 chargers in the US, including 40,000 superchargers, which can charge up to 450 miles per hour and give you a full charge from zero in 40 minutes. Tesla charged cars with ten terawatts of power in 2023, and per kilowatt costs have dropped by 40%, with charge times down 30%. Tesla is well on its way to becoming the largest electric power utility in the United States.

Tesla’s current manufacturing capacity is 2 million cars a year across four factories (Fremont, CA; Austin, TX; Berlin, Germany; and Shanghai, China). While it took Tesla 12 years to make its first million vehicles, the 4th million took only seven months. As of today, it is cheaper to own a Tesla than the world’s biggest formerly biggest-selling car, the Toyota Corolla, given their total lifetime costs. Work out the cost of charging a Tesla, and you are paying the equivalent of 25 cents a gallon for gasoline unless you charge at my house, in which case it is free.

The Gigafactory in Sparks, NV, which mass produces lithium-ion battery packs, is currently being doubled in size. In Texas, Tesla is buying wind power from the grid and offering Tesla owners a flat rate for charging of $30 a month because the cost is so low.

There are great hopes for the Cybertruck, for which Tesla has 2 million orders, myself included. The current price for the three-motor version will be about $80,000, the same as for a model X. The Cybertruck has a brand new third-generation platform on which all future Tesla models will be based. It will also include a 48-volt electrical design.

Tesla’s huge price cuts have been wildly successful, allowing it to gain market share at its competitor's expense. Tesla is really just passing on the recent collapse in commodity prices. So far in 2024, Lithium prices have fallen by 20% and copper by 15%. Tesla prices will continue to fall, especially when the new $25,000 Model 2 is brought to market in 2026. That will really decimate the competition.

Tesla has also taken the plunge into the insurance industry, charging drivers on their actual driving history, which they already collect. If you drive like a little old lady, it can run as little as $125 a month. If you drive like Mad Max, it’s more, but not as much as a conventional car insurance company.

Rates change monthly depending on your driving record. Parked in a garage gives you a perfect score of 90, and it drops from there. It’s all about reducing the total cost of a Tesla car. Not such a bad deal if you let their computer do all the driving.

What will Tesla disrupt next?

All in all, it was a breathtaking presentation, which Elon delivered coolly and calmly. It is with the greatest enthusiasm that I reiterate my $1,000 per share price target.

To watch the Tesla Investor Day in its entirety on YouTube, please click here.

 

 

 

6 X 13.5 kw Tesla Powerwall’s

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

https://www.madhedgefundtrader.com/wp-content/uploads/2023/03/tesla-john-thomas.jpg 251 335 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2024-11-07 09:02:032024-11-07 10:46:44Tesla Special Report: From Here to Infiniti
Mad Hedge Fund Trader

November 7, 2024 - Quote of the Day

Diary, Newsletter, Quote of the Day

“Battles are won with tactics. Wars are won with logistics. The logistics challenges at Tesla are enormous,” said Tesla founder Elon Musk.

 

https://www.madhedgefundtrader.com/wp-content/uploads/2021/01/elon-musk2.png 238 280 Mad Hedge Fund Trader https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Mad Hedge Fund Trader2024-11-07 09:00:202024-11-07 10:46:30November 7, 2024 - Quote of the Day
Mad Hedge Fund Trader

Trade Alert - (GLD) November 6, 2024 - STOP LOSS - SELL

Trade Alert

When John identifies a strategic exit point, he will send you an alert with specific trade information as to what security to sell, when to sell it, and at what price. Most often, it will be to TAKE PROFITS, but on rare occasions, it will be to exercise a STOP LOSS at a predetermined price to adhere to strict risk management discipline. Read more

https://www.madhedgefundtrader.com/wp-content/uploads/2016/02/Alert-e1457452190575.jpg 135 150 Mad Hedge Fund Trader https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Mad Hedge Fund Trader2024-11-06 16:29:372024-11-06 16:37:40Trade Alert - (GLD) November 6, 2024 - STOP LOSS - SELL
Douglas Davenport

AI in Financial Markets: A Double-Edged Sword of Efficiency and Volatility

Mad Hedge AI

Artificial intelligence (AI) is rapidly transforming the financial landscape, promising to revolutionize how markets operate. While AI offers the potential for increased efficiency, deeper liquidity, and superior risk management, it also introduces new challenges and amplifies existing ones. The International Monetary Fund's (IMF) Global Financial Stability Report (GFSR) highlights this duality, emphasizing that AI can make markets more efficient but also more volatile.

The Promise of AI-Driven Efficiency

AI's ability to analyze vast datasets, identify patterns, and make predictions in real-time is reshaping various aspects of financial markets:

  • Enhanced Trading Strategies: AI-powered algorithms can execute trades at lightning speed, optimizing portfolios and capitalizing on fleeting market opportunities. This high-frequency trading (HFT) can improve market liquidity and price discovery.
  • Improved Risk Management: AI algorithms can analyze complex financial data, identify potential risks, and develop sophisticated risk mitigation strategies. This can lead to more accurate credit scoring, fraud detection, and stress testing.
  • Automated Investment Advice: Robo-advisors, powered by AI, can provide personalized investment advice and portfolio management to a wider range of investors, democratizing access to financial services.
  • Streamlined Operations: AI can automate various back-office tasks, such as regulatory compliance, KYC (Know Your Customer) procedures, and data processing, reducing costs and improving efficiency.

The GFSR acknowledges these benefits, noting that AI can "improve risk management and deepen liquidity." This increased efficiency can lead to lower transaction costs, better investment decisions, and ultimately, a more robust financial system.

The Peril of AI-Fueled Volatility

While AI offers significant advantages, it also introduces new complexities and potential risks that can contribute to market volatility:

  • Increased Market Speed and Complexity: The speed and sophistication of AI-driven trading can amplify market fluctuations, especially during times of stress. If multiple AI algorithms react similarly to a market shock, it could trigger a cascade of sell-offs, leading to flash crashes and increased volatility.
  • Black Box Problem: Many AI algorithms, particularly deep learning models, are opaque in their decision-making processes. This "black box" problem can make it difficult to understand why an AI system made a particular trade, hindering regulatory oversight and potentially masking systemic risks.
  • Herding Behavior and Procyclicality: AI algorithms trained on similar datasets or using similar strategies may exhibit herding behavior, amplifying market trends and contributing to procyclicality. This can exacerbate boom-bust cycles and increase systemic risk.
  • Cybersecurity Risks: AI systems are vulnerable to cyberattacks and manipulation. A successful attack could disrupt trading, manipulate market data, or even compromise entire financial institutions, leading to significant volatility and instability.

The GFSR cautions that AI could make markets "opaque, harder to monitor, and more vulnerable to cyber-attacks and manipulation risks." These concerns highlight the need for careful regulation and risk management to mitigate the potential downsides of AI in finance.

Navigating the AI-Powered Market Landscape

To harness the benefits of AI while mitigating its risks, a multi-pronged approach is required:

  • Robust Regulatory Frameworks: Regulators need to adapt to the rapid pace of AI innovation, developing frameworks that promote responsible AI adoption while safeguarding financial stability. This includes ensuring transparency, explainability, and accountability in AI systems.
  • Enhanced Risk Management: Financial institutions must invest in robust risk management frameworks that account for the unique challenges posed by AI, including model risk, data bias, and cybersecurity threats.
  • Collaboration and Information Sharing: Increased collaboration between regulators, financial institutions, and AI developers is crucial to foster a shared understanding of AI risks and develop best practices for its responsible use.
  • Investing in AI Talent and Research: Investing in AI talent and research is essential to stay ahead of the curve and develop innovative solutions to the challenges posed by AI in finance.

Conclusion

AI is undeniably transforming financial markets, offering the potential for increased efficiency and innovation. However, it also introduces new complexities and amplifies existing risks, potentially leading to increased volatility and instability. By embracing a proactive approach to regulation, risk management, and collaboration, we can harness the power of AI while mitigating its potential downsides, ensuring a more efficient and stable financial system for the future.

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 Douglas Davenport https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Douglas Davenport2024-11-06 16:14:042024-11-06 16:14:04AI in Financial Markets: A Double-Edged Sword of Efficiency and Volatility
april@madhedgefundtrader.com

November 6, 2024

Tech Letter

Mad Hedge Technology Letter
November 6, 2024
Fiat Lux

 

Featured Trade:

(TECH STOCKS POISED TO MOVE UP)
($COMPQ), (PLTR), (MSFT), (AMZN), (GOOGL), (INTC)

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2024-11-06 14:04:492024-11-06 16:32:57November 6, 2024
april@madhedgefundtrader.com

Tech Stock Poised To Move Up

Tech Letter

Now that the U.S. election has come and gone with nothing more than a whimper, we are full speed ahead with the last upmove in tech stocks ($COMPQ) for the year 2024.

The beginning of the rally is here, and readers shouldn’t miss it.

A lot of money was waiting on the sidelines, and now we will start seeing institutional money pouring in.

The equity market ripping higher up on the news of a new administration coming to town is a highly bullish signal for the rest of the year for the Nasdaq index.

Chip stocks did quite remarkable today, with the likes of Micron up around 6% at the time of this writing.

I believe that fund managers will hop on and try to achieve the extra alpha now that the biggest risk of an incomplete election is off the table.

The move down in gold by around 3% suggests that fear over the election being inconclusive is off the table.

I don’t envision the new administration starting a witch hunt against tech stocks. Tech stocks still represent a massive motor in the United States economy, which the administration will respect.

Much of the same trends that were occurring before the election continued along the same path, such as a stronger dollar, higher yields, and a weak Japanese yen.

Tech stocks can move higher with all these trends.

In general, a Republican administration should be good for the tech sector, and the corporate taxes will benefit Silicon Valley the most.

First, there's artificial intelligence. The market should expect significant AI initiatives within the U.S. that would be a benefit for Microsoft (MSFT), Amazon (AMZN), Google (GOOGL), and other tech players. Department of Defense AI initiatives would also benefit the likes of Palantir Technologies (PLTR).

Republicans could make major revisions to President Biden's Inflation Reduction Act, which could negatively impact the act's beneficiaries, such as Intel (INTC).

Tesla and its CEO, Elon Musk, will be the biggest beneficiary of a Trump administration. Trump is likely to stop or reduce the electric vehicle rebates and tax incentives. That would be an overall negative for the EV sector but a big positive for Tesla. As will Trump's proposed selective import tariffs.

Tesla has the scale and scope that are unmatched in the EV industry, and this dynamic could give Musk and Tesla a clear competitive advantage in a non-EV subsidy environment, coupled by likely higher China tariffs that would continue to push away cheaper Chinese EV players (BYD, NIO, etc.) from flooding the U.S. market over the coming years.

One of the only few things the Democrats did well was igniting equity prices and, specifically, tech stocks, which is a positive omen moving forward.

Ultimately, a crushing loss by the Democrats revealed another crippling black eye to liberal mainstream media, which should accelerate cord-cutting and the transition to citizen journalism and other independent journalist sources.

Left-wing mainstream media sources wielding radical progressive viewpoints luckily won’t do much collateral damage to tech stocks, and in the backdrop of a strong U.S. economy, I am highly optimistic about tech stocks in the short term.

I believe that the Trump administration will attempt to supercharge tech stocks by cutting red tape and allowing them to flourish.

Reducing taxes will be the bow tie on top to really juice up shareholder returns.

I am bullish on tech stocks going into the end of the year because much of these synergies are still not discounted yet in the price of tech stocks.

 

 

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2024-11-06 14:02:482024-11-06 16:32:15Tech Stock Poised To Move Up
Page 12 of 15«‹1011121314›»

tastytrade, Inc. (“tastytrade”) has entered into a Marketing Agreement with Mad Hedge Fund Trader (“Marketing Agent”) whereby tastytrade pays compensation to Marketing Agent to recommend tastytrade’s brokerage services. The existence of this Marketing Agreement should not be deemed as an endorsement or recommendation of Marketing Agent by tastytrade and/or any of its affiliated companies. Neither tastytrade nor any of its affiliated companies is responsible for the privacy practices of Marketing Agent or this website. tastytrade does not warrant the accuracy or content of the products or services offered by Marketing Agent or this website. Marketing Agent is independent and is not an affiliate of tastytrade. 

Legal Disclaimer

There is a very high degree of risk involved in trading. Past results are not indicative of future returns. MadHedgeFundTrader.com and all individuals affiliated with this site assume no responsibilities for your trading and investment results. The indicators, strategies, columns, articles and all other features are for educational purposes only and should not be construed as investment advice. Information for futures trading observations are obtained from sources believed to be reliable, but we do not warrant its completeness or accuracy, or warrant any results from the use of the information. Your use of the trading observations is entirely at your own risk and it is your sole responsibility to evaluate the accuracy, completeness and usefulness of the information. You must assess the risk of any trade with your broker and make your own independent decisions regarding any securities mentioned herein. Affiliates of MadHedgeFundTrader.com may have a position or effect transactions in the securities described herein (or options thereon) and/or otherwise employ trading strategies that may be consistent or inconsistent with the provided strategies.

Copyright © 2025. Mad Hedge Fund Trader. All Rights Reserved. support@madhedgefundtrader.com
  • Privacy Policy
  • Disclaimer
  • FAQ
Scroll to top